Form 4: SI-BONE Executive Sells Shares to Cover Tax Obligations Following RSU Vesting
Insider Transaction Report
SI-BONE, Inc.'s SVP, Operations & Administration and Chief Legal Officer, Michael A. Pisetsky, sold 3,127 shares of common stock on July 2, 2025, solely to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- Michael A. Pisetsky, SVP, Operations & Administration and Chief Legal Officer of SI-BONE, Inc. (SIBN), reported the sale of 3,127 shares of common stock on July 2, 2025.
- The sales were executed in three separate transactions at weighted average prices of $18.375, $18.3125, and $18.2644 per share.
- The total number of shares beneficially owned by Mr. Pisetsky following these transactions is 261,681, which includes 145,043 shares issuable upon the settlement of restricted stock units.
- The sales were non-discretionary, solely to cover tax withholding obligations associated with the vesting of restricted stock units, and do not represent a discretionary trade.
Sentiment
Score: 5
Explanation: The transaction is a non-discretionary 'sell to cover' to satisfy tax obligations upon RSU vesting, which is a routine event and does not reflect a change in management's outlook or confidence in the company.
Positives
- The underlying vesting of restricted stock units indicates ongoing executive compensation and retention.
Negatives
- The sale of shares, while non-discretionary, reduces the executive's direct shareholding.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Management Comments
- The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.
- The sale satisfies the tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person.
Industry Context
This Form 4 filing details an individual executive's stock transaction and does not provide information relevant to broader industry trends or competitor analysis.
Stakeholder Impact
- Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes, not indicative of a change in company fundamentals or executive confidence.
Key Dates
| Date | Description |
|---|---|
| 07/02/2025 | Date of transaction for the sale of common stock. |
| 07/07/2025 | Date the Form 4 was signed by the Reporting Person. |
Keywords
SI-BONE, SIBN, Form 4, insider transaction, stock sale, restricted stock units, RSU vesting, tax withholding, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.